C3i names Song business development executive in Asia

Monday, July 16, 2012 10:57 AM

C3i, which provides service desk support and business process outsourcing (BPO) services for the life sciences industry, has appointed Jonathan Song business development executive in Asia.

C3i recently opened an operations center in Dalian, China to address the IT support needs of pharmaceutical companies doing business in the main Asian markets. Song will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organizations in Asia.

Song has 20 years of pharmaceutical and healthcare experience in China and the U.S., both in industry and agency, including positions at Merck and Sinopharm.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs